Delivery of mGluR5 siRNAs by Iron Oxide Nanocages by Alternating Magnetic Fields for Blocking Proliferation of Metastatic Osteosarcoma Cells

Although osteosarcoma is the most common primary malignant bone tumor, chemotherapeutic drugs and treatment have failed to increase the five-year survival rate over the last three decades. We previously demonstrated that type 5 metabotropic glutamate receptor, mGluR5, is required to proliferate meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Min A, Rao, Pooja P., Matsui, Hiroshi, Mahajan, Shahana S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320330/
https://www.ncbi.nlm.nih.gov/pubmed/35887290
http://dx.doi.org/10.3390/ijms23147944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320330/
https://www.ncbi.nlm.nih.gov/pubmed/35887290
http://dx.doi.org/10.3390/ijms23147944

Ejemplares similares